First Republic Investment Management, Inc. Karyopharm Therapeutics Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$4.08 - $5.82 $1,342 - $1,914	-329 Reduced 2.67%	12,012 $66,000
Q2 2022 Aug 16, 2022	SELL	$4.15 - $8.37 $2,041 - $4,118	-492 Reduced 3.83%	12,341 $56,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $22,759 - $55,377	-3,851 Reduced 23.08%	12,833 $95,000
Q4 2021 Feb 09, 2022	SELL	$5.21 - $8.61 $3,282 - $5,424	-630 Reduced 3.64%	16,684 $107,000
Q3 2021 Nov 12, 2021	SELL	$4.45 - $10.63 $22,859 - $54,606	-5,137 Reduced 22.88%	17,314 $101,000
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $38,928 - $53,328	4,800 Added 27.19%	22,451 $232,000
Q1 2021 May 14, 2021	SELL	$9.85 - $17.69 $3,546 - $6,368	-360 Reduced 2.0%	17,651 $186,000
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $54,831 - $66,611	-3,875 Reduced 17.71%	18,011 $279,000
Q3 2020 Nov 12, 2020	BUY	$14.14 - $19.71 $99,050 - $138,068	7,005 Added 47.07%	21,886 $320,000
Q2 2020 Aug 13, 2020	BUY	$16.6 - $25.25 $42,927 - $65,296	2,586 Added 21.03%	14,881 $282,000
Q1 2020 May 13, 2020	BUY	$14.38 - $27.72 $176,802 - $340,817	12,295 New	12,295 $236,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account